UnknownNot Applicable

Pack Cross Linking for Infectious Keratitis

Egypt60 participantsStarted 2023-06-15

Plain-language summary

The primary aim of this study is to investigate the efficiency of PACK\_ CXL in treatment of infectious keratitis and analyze postoperative outcomes.

Who can participate

Age range16 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * are age ≥18 years, fungal, bacterial or mixed infectious keratitis, ulcer ≤ 4 mm in diameter and showing a maximum depth of 350 μm (as assessed by either optical coherence tomography (OCT)) Exclusion Criteria: * age ≤18 years, viral infectious keratitis, non-infectiouskeratitis, melting corneal ulcers with impending perforation, corneal thickness \< 400 μm (including the corneal epithelium) and systemic diseases or systemic surgery, single-eyed and immunosuppressed patients.

What they're measuring

corneal THICKNESS

Timeframe: within 60 days

Trial details

NCT IDNCT05881187

SponsorSohag University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-04

Contact for this trial

mariam A mohamed, assistant lecteure

01150960676 mariam-abdelmawgoud@med.sohag.edu.eg

View on ClinicalTrials.gov More Infectoius Keratitis trials